¼¼°èÀÇ ¼­¸Æ Ä¡·á ±â±â ½ÃÀå º¸°í¼­(2025³â)
Bradycardia Treatment Devices Global Market Report 2025
»óǰÄÚµå : 1702994
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,437,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,304,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,172,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼­¸Æ Ä¡·á ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 5.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 112¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ÇコÄɾî ÀÎÇÁ¶ó Áõ°¡, Á¤ºÎ ¹× ¹Î°£ ºÎ¹®ÀÇ ÇコÄɾî ÀÎÇÁ¶ó ÅõÀÚ È®´ë, ½ÉÇ÷°ü °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í ¹× ¿¹¹æ Á¶Ä¡¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ³ë·Â, °æÁ¦ ¼ºÀå, °¡Ã³ºÐ ¼Òµæ Áõ°¡, »õ·Î¿î ÀåÄ¡¿¡ ´ëÇÑ ±ÔÁ¦ ÇÁ·Î¼¼½º ¹× ½ÂÀÎ °£¼ÒÈ­ µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ ¼ºÀå, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü, ¹«µ¶¼º ÀÇ·á±â±â ¹ßÀü, AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ÷´Ü »ýü ÀûÇÕ¼º Àç·áÀÇ »ç¿ë, ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼­¸Æ Ä¡·á ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ¿¡´Â °ü»óµ¿¸ÆÁúȯ, ³úÁ¹Áß, ½ÉºÎÀü µî ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀÌ Æ÷ÇԵ˴ϴÙ. ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡ ¿äÀÎÀ¸·Î´Â ÁÂ½Ä »ýȰ½À°ü, ½Ä½À°ü Àå¾Ö, Èí¿¬, °í·ÉÈ­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ½É¹ÚÁ¶À²±â¿Í °°Àº ¼­¸Æ Ä¡·á ±â±â´Â ½ÉÀ庴 ȯÀÚÀÇ ½ÉÀå ¸®µëÀ» Á¶ÀýÇϰí ÀûÀýÇÑ ½É¹Ú¼ö¸¦ º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ½Ì°¡Æ÷¸£ ÃâÀÔ±¹°ü¸®±¹¿¡ µû¸£¸é ½ÉÀå ¹× °íÇ÷¾Ð¼º ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â 2021³â 6,238¸í¿¡¼­ 2022³â 6,884¸íÀ¸·Î 10.35% Áõ°¡ÇÏ¿© ½ÉÇ÷°ü ÁúȯÀÇ ¿µÇâÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼­¸Æ Ä¡·á ±â±â ½ÃÀåÀÇ È®ÀåÀ» ÃËÁøÇÒ Å¼¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

¼­¸Æ Ä¡·á ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ½Ã¼ú·Î ÀÎÇÑ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¹«µµÀÚÇü ½É¹ÚÁ¶À²±â¸¦ Æ÷ÇÔÇÑ ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¹«½É½Ç Àΰø½ÉÀå¹Úµ¿±â´Â ½ÉÀå¿¡ Á÷Á¢ ½É´Â ¼ÒÇüÀÇ µ¶¸³Çü ÀåÄ¡·Î, ½ÉÀåÀÇ ¸®µëÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ÃÖ¼Ò Ä§½ÀÀû ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ Abbott Laboratories´Â 2023³â 7¿ù AVEIR µà¾ó è¹ö(DR) ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½Ã½ºÅÛ(AVEIR Dual Chamber)¿¡ ´ëÇÑ ¹Ì±¹ FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº µÎ °³ÀÇ ¹«½É¹ÚÁ¶À²±â °£¿¡ µ¿±âÈ­ ¶Ç´Â Á¶Á¤µÈ ½ÉÀå ÆäÀ̽ÌÀ» ¼öÇàÇÏ¿© ½ÉÀå ¸®µëÀÌ ºñÁ¤»óÀûÀ̰ųª ´À¸° ½ÉÀå ¸®µëÀ» °¡Áø ȯÀÚÀÇ Æ¯Á¤ ÀÓ»óÀû ¿ä±¸¸¦ ÃæÁ·½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bradycardia treatment devices are specialized tools used in medical settings to manage slow heart rates, ensuring the heart maintains a healthy rhythm and adequate blood flow throughout the body. These devices play a critical role in addressing cardiac conditions and supporting cardiovascular health.

The main types of bradycardia treatment devices include pacemakers and defibrillators. Pacemakers are medical devices that regulate the heartbeat by delivering electrical impulses to the heart. They are commonly used to treat conditions such as sinus bradycardia, sinus pause, sick sinus syndrome, tachy-brady syndrome, and heart block. These devices are typically utilized by hospitals, specialty clinics, and other healthcare facilities.

The bradycardia treatment devices market research report is one of a series of new reports from The Business Research Company that provides bradycardia treatment devices market statistics, including the bradycardia treatment devices industry's global market size, regional shares, competitors with a bradycardia treatment devices market share, detailed bradycardia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the bradycardia treatment devices industry. This bradycardia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bradycardia treatment devices market size has grown strongly in recent years. It will grow from $8.54 billion in 2024 to $9.04 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of cardiovascular diseases, growth in the elderly population, increasing awareness and screening programs, regulatory approvals and launches, and increasing healthcare expenditure.

The bradycardia treatment devices market size is expected to see strong growth in the next few years. It will grow to $11.26 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing healthcare infrastructure, governments, and private sectors investing more in healthcare infrastructure, continued efforts to raise awareness and implement preventive measures for cardiovascular health, economic growth, increasing disposable income, and streamlined regulatory processes and approvals for new devices. Major trends in the forecast period include growth in telemedicine and remote monitoring technologies, advances in personalized medicine, advancement in leadless pacemakers, integration of AI and machine learning, use of advanced biocompatible materials, and integration of telehealth services.

The increasing prevalence of cardiovascular disease is expected to drive growth in the bradycardia treatment devices market. Cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. Factors contributing to the rising prevalence of cardiovascular disease include sedentary lifestyles, poor dietary habits, smoking, and an aging population. Bradycardia treatment devices, such as pacemakers, play a critical role in regulating heart rhythm and ensuring adequate heart rate in patients with cardiac disorders. For example, according to the Immigration and Checkpoints Authority in Singapore, deaths from heart and hypertensive diseases increased by 10.35% in 2022 to 6,884 deaths from 6,238 recorded in 2021, underscoring the impact of cardiovascular conditions. Thus, the growing prevalence of cardiovascular disease is poised to fuel expansion in the bradycardia treatment devices market.

Leading companies in the bradycardia treatment devices market are focused on advancing solutions, including leadless pacemakers, to enhance patient outcomes and minimize procedural complications. Leadless pacemakers are small, self-contained devices implanted directly into the heart without the use of leads, offering a minimally invasive option for managing heart rhythm. For instance, Abbott Laboratories, a US-based medical device manufacturer, received US FDA approval in July 2023 for the AVEIR dual chamber (DR) leadless pacemaker system. This system provides synchronized or coordinated cardiac pacing between two leadless pacemakers, tailored to the specific clinical needs of patients with abnormal or slow heart rhythms.

In September 2022, Ceryx Medical Ltd., based in the UK, collaborated with Osypka Medical GmbH to develop Cysoni, a heart-pacing device aimed at treating heart failure and other cardiac conditions. This partnership leverages the expertise of both companies in the development of innovative bradycardia treatment devices. Osypka Medical GmbH, headquartered in Germany, specializes in manufacturing medical devices for the treatment of cardiac disorders.

Major companies operating in the bradycardia treatment devices market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Zoll Medical Corporation, Biotronik Medical Devices India Private Limited, Lepu Medical Technology Co. Ltd., Integer Holdings Corporation, Nihon Kohden India Pvt. Ltd., Livanova India Private Limited, Microport Scientific India Private Limited, Fukuda Denshi Co. Ltd., Trivitron Healthcare Private Limited, Sorin Group, Physio-Control Inc., OSCOR Inc., Medico S.R.L., Amaryllis Healthcare Pvt. Ltd., Inorbvict Healthcare India Private Limited, Kox Med And Lab Private Limited, Nasan Medical Electronics Pvt Ltd, Osypka Medical Asia Co., Ltd., Shree Pacetronix Limited, Medinnova Systems Pvt. Ltd.

North America was the largest region in the bradycardia treatment devices market in 2024. The regions covered in the bradycardia treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bradycardia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bradycardia treatment devices market consists of sales of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and leadless pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bradycardia Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bradycardia treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bradycardia treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bradycardia treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bradycardia Treatment Devices Market Characteristics

3. Bradycardia Treatment Devices Market Trends And Strategies

4. Bradycardia Treatment Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bradycardia Treatment Devices Growth Analysis And Strategic Analysis Framework

6. Bradycardia Treatment Devices Market Segmentation

7. Bradycardia Treatment Devices Market Regional And Country Analysis

8. Asia-Pacific Bradycardia Treatment Devices Market

9. China Bradycardia Treatment Devices Market

10. India Bradycardia Treatment Devices Market

11. Japan Bradycardia Treatment Devices Market

12. Australia Bradycardia Treatment Devices Market

13. Indonesia Bradycardia Treatment Devices Market

14. South Korea Bradycardia Treatment Devices Market

15. Western Europe Bradycardia Treatment Devices Market

16. UK Bradycardia Treatment Devices Market

17. Germany Bradycardia Treatment Devices Market

18. France Bradycardia Treatment Devices Market

19. Italy Bradycardia Treatment Devices Market

20. Spain Bradycardia Treatment Devices Market

21. Eastern Europe Bradycardia Treatment Devices Market

22. Russia Bradycardia Treatment Devices Market

23. North America Bradycardia Treatment Devices Market

24. USA Bradycardia Treatment Devices Market

25. Canada Bradycardia Treatment Devices Market

26. South America Bradycardia Treatment Devices Market

27. Brazil Bradycardia Treatment Devices Market

28. Middle East Bradycardia Treatment Devices Market

29. Africa Bradycardia Treatment Devices Market

30. Bradycardia Treatment Devices Market Competitive Landscape And Company Profiles

31. Bradycardia Treatment Devices Market Other Major And Innovative Companies

32. Global Bradycardia Treatment Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bradycardia Treatment Devices Market

34. Recent Developments In The Bradycardia Treatment Devices Market

35. Bradycardia Treatment Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â